RxDoctor Payments Data

Shayna Walker, MD

Family Medicine · Tampa, FLNPI 1760688295

Payments from drug & device makers

$1,206in general payments, 2019–2025

Across 65 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$307
  • Sunovion Pharmaceuticals Inc.$203
  • Vanda Pharmaceuticals Inc.$174
  • Johnson & Johnson$143
  • Otsuka America Pharmaceutical, Inc.$98
  • AbbVie$74
  • plus $206 from 5 others

What the payments were for

  • Food & beverage$1,14595%
  • Education$615%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,206 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$26,929
Medicare patients
51
Services billed
333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl16$10,128
TrintellixVortioxetine Hydrobromide16$7,557
Bupropion XlBupropion Hcl69$2,013
Quetiapine Fumarate76$1,791
Aripiprazole39$1,601
Ramelteon14$1,133
Zolpidem Tartrate ErZolpidem Tartrate13$1,104
Duloxetine Hcl49$981
Hydroxyzine Hcl40$754
Buspirone Hcl54$685
Doxazosin Mesylate67$564
Venlafaxine Hcl ErVenlafaxine Hcl32$509
Trazodone Hcl54$441
Olanzapine16$364
Lorazepam83$327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$42$7,55716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →